Control Group

Treatment Group

Number of patients

30

32

Age, years

62 ± 7

62 ± 7

Sex (male/female)

10/20

10/22

Duration of symptoms prior to presentation, months

2.5 ± 1.9

3.0 ± 1.4

BCVA, letters

65 ± 13

64 ± 14

CRT, μm

385.3 ± 8.3

406.3 ± 23.3

RCT, sec

5.15 ± 0.21

5.11 ± 0.29